Meta-Analysis of High-Risk Sexual Behavior in Persons Aware and Unaware They are Infected With HIV in the United States

Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention (CDC), Atlanta, GA 30333, USA.
JAIDS Journal of Acquired Immune Deficiency Syndromes (Impact Factor: 4.56). 09/2005; 39(4):446-53. DOI: 10.1097/01.qai.0000151079.33935.79
Source: PubMed


To compare the prevalence of high-risk sexual behaviors in HIV persons aware of their serostatus with that in HIV persons unaware of their status in the United States and to discuss implications for HIV prevention programs.
A meta-analysis was conducted on 11 independent findings. Six findings compared HIV(+) aware persons with independent groups of HIV(+) unaware persons (between-group comparisons), and 5 findings compared seroconverting individuals before and after being notified of their HIV status (within-subject comparisons). Outcomes were self-reported unprotected anal or vaginal intercourse (UAV) during specified recall periods.
The analysis integrating all 11 findings indicated that the prevalence of UAV with any partner was an average of 53% (95% confidence interval [CI]: 45%-60%) lower in HIV persons aware of their status relative to HIV(+) persons unaware of their status. There was a 68% reduction (95% CI: 59%-76%) after adjusting the data of the primary studies to focus on UAV with partners who were not already HIV(+). The reductions were larger in between-group comparisons than in within-subject comparisons. Findings for men and women were highly similar.
The prevalence of high-risk sexual behavior is reduced substantially after people become aware they are HIV(+). Increased emphasis on HIV testing and counseling is needed to reduce exposure to HIV(+) from persons unaware they are infected. Ongoing prevention services are needed for persons who know they are HIV(+) and continue to engage in high-risk behavior.

Download full-text


Available from: Nicole Crepaz, Sep 29, 2015
1 Follower
281 Reads
  • Source
    • "Timely diagnosis and retention in HIV treatment create a virtuous cycle promoted by the display of better quality of life and prolonged survival time for people with HIV. ART among people with HIV produces preventive benefits by decreasing the HIV plasma concentration in a given population [8] [9] [10] and reducing risk behavior through knowledge of infection status [11]. On the other hand, the use of ART may also facilitate HIV transmission due to a greater number of cases in the prevalence pool [12], behavior disinhibition [13], increased drug resistance [6], poor access to care services [14], and variations in the transmission routes of the targeted population [14]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The preventative effects of antiretroviral therapy for people with HIV have been debated since they were first raised. Models commenced studying the preventive effects of treatment in the 1990s, prior to initial public reports. However, the outcomes of the preventive effects of antiretroviral use were not consistent. Some outcomes of dynamic models were based on unfeasible assumptions, such as no consideration of drug resistance, behavior disinhibition, or economic inputs in poor countries, and unrealistic input variables, for example, overstated initiation time, adherence, coverage, and efficacy of treatment. This paper reviewed dynamic mathematical models to ascertain the complex effects of ART on HIV transmission. This review discusses more conservative inputs and outcomes relative to antiretroviral use in HIV infections in dynamic mathematical models. ART alone cannot eliminate HIV transmission.
    12/2014; 2014:760734. DOI:10.1155/2014/760734
  • Source
    • "Please address correspondence to Nancy M. Petry, University of Connecticut Health Center, 263 Farmington Ave, Farmington, CT, 06030; email: Persons living with HIV/AIDS are the only ones who can transmit HIV, and those who are unaware of being HIV-infected contribute to the majority of new HIV infections (Centers for Disease Control 2008; Marks, Crepaz & Janssen 2006; Marks et al. 2005). As a result, the Centers for Disease Control and Prevention (CDC) (2011) recommends routine HIV testing in a number of settings, including substance abuse treatment programs that serve individuals at high risk for contracting HIV (Branson et al. 2006; Metsch et al. 2012; Substance Abuse and Mental Health Service Administration (SAMHSA) 2011; Winstanley, Gust & Strathdee 2006). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Abstract Routine testing is the cornerstone to identifying HIV, but not all substance abuse treatment patients have been tested. This study is a real-world evaluation of predictors of having never been HIV tested among patients initiating substance abuse treatment. Participants (N = 614) from six New England clinics were asked whether they had ever been HIV tested. Eighty-five patients (13.8%) reported having never been tested and were compared to those who had undergone testing. Clinic, male gender (adjusted odds ratio (AOR) = 1.91, 95% confidence interval (CI) = 1.07-3.41), and having fewer employment (AOR = 0.31; 95% CI = 0.11-0.88) and medical problems (AOR = 0.40, 95% CI = 0.17-0.99) were independently correlated with having never been HIV tested. Thus, there is still considerable room for improved testing strategies as a clinically significant minority of substance abuse patients have never undergone HIV testing when they initiate treatment.
    Journal of psychoactive drugs 07/2014; 46(3):208-214. DOI:10.1080/02791072.2014.915363 · 1.10 Impact Factor
  • Source
    • "Access to and timely uptake of HIV testing is a necessary precursor to receiving the most effective care and treatment for people infected with HIV [1]. Processes around testing itself, such as counseling, may even help limit ongoing transmission risks among those uninfected [2-4]. Therefore, effective HIV testing needs to be a vital component of a country’s comprehensive public health policy. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Understanding HIV testing behaviour is vital to developing evidence-based policy and programming that supports optimal HIV care, support, and prevention. This has not been investigated among younger gay, bisexual, and other men who have sex with men (YMSM, aged 16-29) in New Zealand. National HIV sociobehavioural surveillance data from 2006, 2008, and 2011 was pooled to determine the prevalence of recent HIV testing (in the last 12 months) among YMSM. Factors associated with recent testing were determined using manual backward stepwise multivariate logistic regression. Of 3,352 eligible YMSM, 1,338 (39.9%) reported a recent HIV test. In the final adjusted model, the odds of having a recent HIV test were higher for YMSM who were older, spent more time with other gay men, reported multiple sex partners, had a regular partner for 6-12 months, reported high condom use with casual partners, and disagreed that HIV is a less serious threat nowadays and that an HIV-positive man would disclose before sex. The odds of having a recent HIV test were lower for YMSM who were bisexual, recruited online, reported Pacific Islander or Asian ethnicities, reported no regular partner or one for >3 years, were insertive-only during anal intercourse with a regular partner, and who had less HIV-related knowledge. A priority for HIV management should be connecting YMSM at risk of infection, but unlikely to test with appropriate testing services. New generations of YMSM require targeted, culturally relevant health promotion that provides accurate understandings about HIV transmission and prevention.
    BMC Public Health 03/2014; 14(1):294. DOI:10.1186/1471-2458-14-294 · 2.26 Impact Factor
Show more